Description: Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Home Page: www.zymergen.com
ZY Technical Analysis
5980 Horton Street
EmeryVille,
CA
94608
United States
Phone:
415 801 8073
Officers
| Name | Title |
|---|---|
| Ms. Enakshi Singh | Chief Financial Officer |
| Mr. Dmitriy Ryaboy | Chief Technology Officer |
| Mike Dulin | Director of Communications |
| Mr. Lincoln Germain | Chief Commercial Officer |
| Mr. Subodh S. Deshmukh | Chief Devel. Officer |
| Mr. Devin Scannell | Sr. VP of Drug Discovery |
| Mr. Duane Valz J.D. | Sec. |
| Ms. Mina Kim | Corp. Sec. |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0717 |
| Price-to-Sales TTM: | 17.3937 |
| IPO Date: | 2021-04-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 502 |